(Q42201806)

18 October 2017

Optimization of the Protocol for the Isolation and Refolding of the Extracellular Domain of HER2 Expressed in Escherichia coli (English)

1 reference

18 October 2017

1 reference

Escherichia coli

1 reference

V V Dolgikh

1

1 reference

18 October 2017

I V Senderskiy

series ordinal

2

1 reference

18 October 2017

G V Tetz

series ordinal

3

1 reference

18 October 2017

V V Tetz

series ordinal

4

1 reference

18 October 2017

language of work or name

1 reference

1 April 2014

1 reference

18 October 2017

1 reference

18 October 2017

6

1 reference

18 October 2017

2

1 reference

18 October 2017

106-109

1 reference

The mannosylated extracellular domain of Her2/neu produced in P. pastoris induces protective antitumor immunity

18 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Utility of serum HER2 extracellular domain assessment in clinical decision making: pooled analysis of four trials of trastuzumab in metastatic breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Molecular mechanisms of erbB2-mediated breast cancer chemoresistance

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Growth inhibition of breast cancer cell lines overexpressing Her2/neu by a novel internalized fully human Fab antibody fragment

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Making the most of affinity tags

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Signal transduction and oncogenesis by ErbB/HER receptors

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

DITHIOTHREITOL, A NEW PROTECTIVE REAGENT FOR SH GROUPS

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Preparative and analytical purification of DNA from agarose

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

A generic protocol for the expression and purification of recombinant proteins in Escherichia coli using a combinatorial His6-maltose binding protein fusion tag.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Purification and characterization of recombinant extracellular domain of human HER2 from Escherichia coli.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Serum levels of HER2 ECD can determine the response rate to low dose oral cyclophosphamide and methotrexate in patients with advanced stage breast carcinoma

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Effect of dose on immune response in patients vaccinated with an her-2/neu intracellular domain protein--based vaccine

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Serum HER-2 extracellular domain (ECD) before the first metastasis in 128 breast cancer patients.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115232

Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25093117

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25093117

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

18 October 2017

1 reference